Despite the rollout and expansion of TrumpRx, some experts argue the platform is “not a solution” for many patients.
Speaking to the Guardian earlier this year, Sean Sullivan, a professor of health economics and policy and former dean of pharmacy at the University of Washington, said: “Consumers can probably get a cheaper version of these medicines through insurance and their pharmacies, or via cash pay services like Cost Plus Drugs than by the deals offered through TrumpRx.”…
https://www.theguardian.com/us-news/2026/may/18/trumprx-site-prescription-drugs
No comments:
Post a Comment